Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors

Randomized Study of Autologous Cytokine-Induced Killer Cell Immunotherapy in Metastatic Renal Carcinoma

(2012) L. Liu et al.   CLINICAL CANCER RESEARCH

Adoptive Immunotherapy with Cytokine-Induced Killer Cells for Patients with Relapsed Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

(2011) Ginna G. Laport et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity

(2011) A. Pievani et al.   BLOOD

Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy

(2011) S. A. Rosenberg et al.   CLINICAL CANCER RESEARCH

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

(2011) Eva Rettinger et al.   CYTOTHERAPY

Cord blood-derived cytokine-induced killer cells biotherapy combined with second-line chemotherapy in the treatment of advanced solid malignancies

(2011) Qi Niu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Ipilimumab in Treatment-naive and Previously Treated Patients with Metastatic Melanoma

(2011) John A. Thompson et al.   JOURNAL OF IMMUNOTHERAPY

Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one?

(2011) Sharmilan Thanendrarajan et al.   LEUKEMIA RESEARCH

Cell transfer immunotherapy for metastatic solid cancer—what clinicians need to know

(2011) Steven A. Rosenberg   Nature Reviews Clinical Oncology

Dendritic cell-activated cytokine-induced killer cells enhance the anti-tumor effect of chemotherapy on non-small cell lung cancer in patients after surgery

(2010) Hui Li et al.   CYTOTHERAPY

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation

(2010) S. Kuci et al.   HAEMATOLOGICA

Cytokine-Induced NK-Like T Cells: From Bench to Bedside

(2010) Yeh Ching Linn et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC)

(2010) C. Hontscha et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

(2010) Qun Zhao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokine-induced killer (CIK) cells in clinical-grade cultures

(2010) Giuseppina Bonanno et al.   Journal of Translational Medicine

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients

(2010) Jing-Ting Jiang   WORLD JOURNAL OF GASTROENTEROLOGY

Antitumor activity of cytokine-induced killer cells in nude mouse xenograft model

(2009) Hwan Mook Kim et al.   ARCHIVES OF PHARMACAL RESEARCH

Human Cytokine-Induced Killer Cells Specifically Infiltrated and Retarded the Growth of the Inoculated Human Cholangiocarcinoma Cells in SCID Mice

(2009) Adisak Wongkajornsilp et al.   CANCER INVESTIGATION

Cytokine-induced killer cells are terminallydifferentiated activated CD8 cytotoxic T-EMRA lymphocytes

(2009) Marta Franceschetti et al.   EXPERIMENTAL HEMATOLOGY

Immunotherapy with cytokine induced killer cells in solid and hematopoietic tumours: a pilot clinical trial

(2009) Paola Olioso et al.   HEMATOLOGICAL ONCOLOGY

Minimally Invasive Treatment Combined With Cytokine-induced Killer Cells Therapy Lower the Short-term Recurrence Rates of Hepatocellular Carcinomas

(2009) De-Sheng Weng et al.   JOURNAL OF IMMUNOTHERAPY

Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study

(2009) Jedd D Wolchok et al.   LANCET ONCOLOGY

In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity

(2008) R. Nishimura et al.   BLOOD

A randomized, controlled trial of postoperative adjuvant cytokine-induced killer cells immunotherapy after radical resection of hepatocellular carcinoma

(2008) Dong Hui et al.   DIGESTIVE AND LIVER DISEASE

Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell

(2008) Yeh C. Linn et al.   IMMUNOLOGY

Alloreactivity and anti-tumor activity segregate within two distinct subsets of cytokine-induced killer (CIK) cells: implications for their infusion across major HLA barriers

(2008) Dario Sangiolo et al.   INTERNATIONAL IMMUNOLOGY

Inhibition of human cervical carcinoma growth by cytokine-induced killer cells in nude mouse xenograft model

(2008) Hwan Mook Kim et al.   INTERNATIONAL IMMUNOPHARMACOLOGY